Trial site
Hospital Clinico Universitario de Salamanca
- 25running trials
- 12closed trials
The trials here
What the 38 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease5 trials
- Myeloproliferative neoplasms5 trials
- Acute myeloid leukaemia3 trials
- Heart failure3 trials
- Multiple myeloma3 trials
- Diffuse large B-cell lymphoma2 trials
- Mantle cell lymphoma2 trials
- Myelodysplastic syndromes2 trials
- Aortic stenosis1 trial
- Asthma1 trial
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- and 7 more
- Phase
- Phase 311 trials
- Phase 28 trials
- Phase 1/23 trials
- Phase 12 trials
- Phase 41 trial
- Status
- Active, not recruiting12 trials
- Recruiting11 trials
- Completed7 trials
- Terminated4 trials
- Not yet recruiting2 trials
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Incyte Corporation10 trials
- Fundación EPIC7 trials
- Alleviant Medical, Inc.2 trials
- PETHEMA Foundation2 trials
- Regeneron Pharmaceuticals2 trials
- and 15 more
Running trials
Recruiting
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Active, not recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
Active, not recruiting
Recruiting
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
Active, not recruiting
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Heart failure3 recruiting
- Acute myeloid leukaemia1 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Withdrawn
Completed
Terminated
Terminated
Terminated
Completed
Study of Early Relapsed, Lenalidomide-refractory Subjects Eligible for Carfilzomib Triplet
Completed
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026